Citadel Advisors »

Bridgebio Pharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $26k 24k 1.08
2023-09-30 $5.3M 5.5M 0.96
2021-12-31 $54M 74M 0.74
2021-09-30 $159M 115M 1.38
2021-06-30 $121M 74M 1.64
2021-03-31 $74M 45M 1.66

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Bridgebio Pharma

Braidwell
Graham Capital Management
Wolverine Asset Management
Aristeia Capital
Weiss Asset Management LP[1
D. E. Shaw & Co
683 Capital Management
Lazard Asset Management
Affinity Asset Advisors
Wells Fargo & Company
Point72 Asset Management
State Street Corporation
Calamos Advisors
Advent Capital Management
Ubs Global Asset Management Americas

View all funds holding Bridgebio Pharma